Traditional and Novel Risk Factors in Atherothrombosis

Atherothrombosis has reached pandemic proportions worldwide. It is the underlying condition that results in events leading to myocardial infarction, ischemic stroke and vascular death. As such, it is the leading cause of death worldwide manifested mainly as cardiovascular/cerebrovascular death. The...

Full description

Saved in:
Bibliographic Details
Other Authors: Gaxiola, Efrain (Editor)
Format: Book Chapter
Published: IntechOpen 2012
Subjects:
Online Access:Get Fullteks
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 01855naaaa2200289uu 4500
001 doab_20_500_12854_66008
005 20210420
020 |a 1062 
020 |a 9789535105619 
020 |a 9789535169826 
024 7 |a 10.5772/1062  |c doi 
041 0 |a English 
042 |a dc 
072 7 |a MJD  |2 bicssc 
100 1 |a Gaxiola, Efrain  |4 edt 
700 1 |a Gaxiola, Efrain  |4 oth 
245 1 0 |a Traditional and Novel Risk Factors in Atherothrombosis 
260 |b IntechOpen  |c 2012 
300 |a 1 electronic resource (154 p.) 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Atherothrombosis has reached pandemic proportions worldwide. It is the underlying condition that results in events leading to myocardial infarction, ischemic stroke and vascular death. As such, it is the leading cause of death worldwide manifested mainly as cardiovascular/cerebrovascular death. The complex and intimate relationship between atherothrombosis and traditional and novel risk factors is discussed in the following chapters of Traditional and Novel Risk Factors in Atherothrombosis - from basic science to clinical and therapeutic concerns. Beginning with pathology and pathophysiology of atherothrombosis, plaque rupture/disruption, this book continues with molecular, biochemical, inflammatory, cellular aspects and finally analyzes several aspects of clinical pharmacology. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/3.0/  |2 cc  |4 https://creativecommons.org/licenses/by/3.0/ 
546 |a English 
650 7 |a Cardiovascular medicine  |2 bicssc 
653 |a Cardiovascular medicine 
856 4 0 |a www.oapen.org  |u https://mts.intechopen.com/storage/books/552/authors_book/authors_book.pdf  |7 0  |z Get Fullteks 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/66008  |7 0  |z DOAB: description of the publication